Tweenvest Stocks

Cann Group Limited (ASX: CAN)

Health Care · Pharmaceuticals · AU

AU$0.00

+20.00% today · -75.0% 1Y

Cann Group Limited (ASX: CAN) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $3.57M and employs 40 people.

Over the last twelve months the share price has lost 75.0%, trading between 0.00 and 0.02.

Tweenvest scores Cann Group Limited across four factors: quality 21/100, value 46/100, growth 100/100. Its strongest factor is growth.

CAN price history

Not enough price history to draw a chart yet.

Key figures

Market cap
$3.57M
Revenue (TTM)
$7.54M
P/E
0.14
EPS
0.02
Dividend yield
Beta (5Y)
0.05
52-week high
AU$0.02
52-week low
AU$0.00
Avg volume (3M)
Shares outstanding
1.66B
Employees
40
Next earnings

About Cann Group Limited

Cann Group Limited, established in Port Melbourne, Australia, in 2014, specializes in the comprehensive lifecycle of medicinal cannabis. This includes genetic development, cultivation, manufacturing, clinical assessment, and the distribution of therapeutic cannabis products. The company supplies these products for use within Australia and also exports them to international markets, operating under specific licenses that permit research and the cultivation of cannabis for human medicinal and scientific purposes.

ISIN
AU000000CAN2
Founded
2014
Listed since
May 5, 2017
Exchange
Australian Securities Exchange
Currency
AUD
CompanyMarket capPriceDay
Eli Lilly and CompanyNYSE: LLY$1.11T$1,246.93-0.67%
Johnson & JohnsonNYSE: JNJ$658.00B$273.04+1.04%
Merck & Co., Inc.NYSE: MRK$371.70B$150.66-1.24%
Roche Holding AGSWX: ROP$368.80BCHF370.40-1.38%
Novartis AGSWX: NOVN$300.52BCHF126.76-0.52%
AstraZeneca PLCLSE: AZN$256.25B£121.10-1.06%
Novo Nordisk A/SCPSE: NOVO B$206.64BDkr299.25-0.53%
Pfizer Inc.NYSE: PFE$159.42B$27.97-0.36%

Browse every Pharmaceuticals company →

Figures last refreshed Aug 18, 2026.